NCT03287843已完成不适用
Effect of Timing of Surgery After Neoadjuvant Chemoradiation on Histopathological Results, Complications, Recurrence and Survivals for Locally Advanced Rectal Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 350
- 主要终点
- Pathological Complete Response Rate
研究概览
简要总结
This study aimed to compare the outcomes of early versus late surgical resection in patients who underwent curative total mesorectal excision after neoadjuvant chemoradiation. Half of the participants will undergo surgery before 8 weeks, while the other half will undergo surgery after 8 weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinic stage II-III cancer ( T3- T4 tm or/and N(+) disease )
- •Patients with histologically confirmed adenocarcinoma of the rectum
- •Tumor distal border located within 15 cm. from anal verge (as measured by rigid rectoscopy)
- •Standardized total mesorectal excision surgery
- •Tumor must be clinically resectable with curative intent (R0 resection must be most likely)
- •Elective operation
- •The patient must consent to be in the study and the informed consent must be signed
排除标准
- •Clinic stage I and IV cancer disease
- •Patients with malignant disease of the rectum other than adenocarcinoma
- •Recurrent rectal cancer
- •Emergency cases (Mechanical bowel obstruction, perforation)
- •Other previous or concurrent malignancies
- •Any contraindication for radiochemotherapy
- •Previous chemotherapy or radiotherapy to the pelvis
- •Tumor has arisen from chronic inflammatory bowel disease or hereditary polyposis disease
- •American Society of Anesthesiologists Score >3 patients
结局指标
主要结局
Pathological Complete Response Rate
时间窗: 2 months
Complete pathological response, defined as the absence of viable tumor cells, may develop after neoadjuvant treatment for rectal cancer. Prognostic factors affecting pathological complete response will be evaluated.
次要结局
- Disease-free Survival(5 years after surgery)
- Tumour Regression Grade(30 days after surgery)
- Surgical Complications(90 days after surgery)
- Overall Survival(5 years after surgery)
- Completeness of the Mesorectal Dissection(30 days after surgery)
- Recurrence(5 years after surgery)
研究者
Zekeriya Erhan Akgün
Professor of surgery
Ege University
相似试验
进行中（未招募）
不适用
Study of Upfront surgery versus Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery for Patients with Stage IIIC and IV Ovarian CancerNeoplasmsKCT0005870Seoul National University Hospital456
已完成
不适用
Timing of Resective Surgery After Neoadjuvant Chemoradiotherapy in Esophageal CancerCancer of the EsophagusNCT02415101Karolinska University Hospital202
已完成
不适用
Clinical Outcomes of Surgery After Neoadjuvant Chemotherapy in Locally Advanced Pancreatic CancerPostoperative ComplicationsNCT05888129Asan Medical Center1
已完成
不适用
Assessment of Efficacy of Neoadjuvant Therapy in Locally Advanced Rectal CancerLocally Advanced Rectal CarcinomaNCT06314737Sixth Affiliated Hospital, Sun Yat-sen University3,515
招募中
不适用
Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and SacrumOsteosarcoma of PelvisNCT03360760Peking University People's Hospital100